Brief: Cocrystal Pharma To Present Cc-42344 Phase 1 Influenza A Data At The World Antiviral Congress 2022
13/10/2022 13:04
Oct 13 (Reuters) - Cocrystal Pharma Inc COCP.O :
* COCRYSTAL PHARMA TO PRESENT CC-42344 PHASE 1 INFLUENZA A
DATA AT
THE WORLD ANTIVIRAL CONGRESS 2022
Source text for Eikon: ID:nGNX4Bml4w
Further company coverage: COCP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway